Filing Flows › Hims & Hers Health (HIMS) › Q3 2026 › vs Q3 2025
Hims & Hers Health (HIMS) Q3 2026 vs Q3 2025 (year over year)
Hims & Hers Health's revenue rose $291M (+49%) from $599M in Q3 2025 to $890M in Q3 2026.
Hims & Hers Health, Q3 2026: revenue $890M (+49% year over year), operating margin -7.4%, net loss $33.0M, operating cash flow $65.4M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 2.9% | 13.2% | -10.3 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $890M | $599M | $291M | +49% |
| Other income, net | $19.9M | $416K | $19.5M | 48× |
| Income tax benefit | $13.2M | $3.6M | $9.7M | +272% |
| Net loss | $33.0M | −$15.8M | $48.8M | — |
| Costs & expenses | $957M | $603M | $354M | +59% |
| Operating costs | $957M | $587M | $369M | +63% |
| Cost of revenue | $381M | $157M | $224M | +143% |
| General & admin | $151M | $80.7M | $70.8M | +88% |
| Other operating costs | $424M | $350M | $74.3M | +21% |
| Operating cash sources | $103M | $57.8M | $44.8M | +78% |
| Depreciation & amortization | $38.2M | $17.7M | $20.5M | +116% |
| Share-based compensation | $64.5M | $40.2M | $24.3M | +61% |
| Net loss absorbed | $33.0M | −$15.8M | $48.8M | — |
| Working capital & other | $4.3M | −$75.1M | $79.4M | — |
| Operating cash flow | $65.4M | $149M | −$83.3M | -56% |
| Free Cash Flow (company-reported) | $26.0M | $79.4M | −$53.4M | -67% |
| Purchases of property, equipment, and intangible assets in investing activities | $33.3M | $65.3M | −$32.0M | -49% |
| Investment in website development and internal-use software in investing activities | $6.1M | $4.1M | $2.0M | +50% |
Questions
How much did Hims & Hers Health's revenue grow year over year in Q3 2026?
Hims & Hers Health's revenue rose $291M (+49%) from $599M in Q3 2025 to $890M in Q3 2026.